AI-generated summary
In a study of 15 participants with rosacea, the authors report that three sessions of combined 532-nm KTP and 1064-nm Nd:YAG laser therapy, given three weeks apart, were associated with lower erythema scores and improved quality-of-life scores. Most participants showed some clinical improvement, and no severe adverse events were reported. The study was small and the abstract does not describe a control group.
- Participants
- 15
- Who or what was studied
- 15 participants with rosacea
- Wavelengths
- 532, 1064 nm
- Limits stated in the abstract
- The sample is small (15 participants) and the abstract does not describe a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.